Patents by Inventor Georg Kottirsch

Georg Kottirsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxamic acid derivatives
    Patent number: 6500983
    Abstract: Novel hydroxamic acid compounds, e.g., of formula I, wherein R1, R2, R3 and R4 are as defined, are found to be useful as pharmaceuticals, e.g., for the suppression of TNF release and the treatment of autoimmune and inflammatory diseases, e.g., multiple sclerosis and rheumatoid arthritis. Methods of making the compounds, novel intermediates, and pharmaceutical compositions comprising the compounds are provided.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: December 31, 2002
    Assignee: Novartis AG
    Inventors: Georg Kottirsch, Ulf Neumann
  • Hydroxamic acid derivatives
    Publication number: 20020038045
    Abstract: Novel hydroxamic acid compounds, e.g.
    Type: Application
    Filed: October 9, 2001
    Publication date: March 28, 2002
    Inventors: Georg Kottirsch, Ulf Neumann
  • Pseudopeptide isosteres of gly-asp and their use as antithrombic agents
    Patent number: 5561112
    Abstract: Pseudopeptides of formula I in free or salt form ##STR1## wherein A, B, R.sub.1, X, Y and m are defined as in claim 1, and their use in the prophylactic and acute treatment of thrombosis.
    Type: Grant
    Filed: March 1, 1994
    Date of Patent: October 1, 1996
    Assignee: Sandoz Ltd.
    Inventors: Georg Kottirsch, Rainer Metternich